CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-09-03 | THORNLEY ANTHONY S Director | Purchase | +200 | $1.65 | $330 | 54,600 |
| 2008-09-02 | THORNLEY ANTHONY S Director | Purchase | +200 | $1.50 | $300 | 54,400 |
| 2008-06-27 | THORNLEY ANTHONY S Director | Purchase | +4,200 | $1.74 | $7K | 54,200 |
| 2008-04-24 | Lomoro John T Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2008-04-24 | Singh Juliet CEO, Director and President | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 |
Page 21 of 21 · 405 trades